Mangalam Drugs & Organics Q2 Results
- BSE: 532637
- NSE: MANGALAM
- ISIN: INE584F01014
- Sector: Biotechnology & Drugs
BSE
105.85
-1.05 (-0.98%)
-1.05 (-0.98%)Volume2.28 K
Updated: Mon 25 Nov, 2024 | 15:28:14
NSE
106.02
1.00 (0.95%)
1.00 (0.95%)Volume15.90 K
Updated: Mon 25 Nov, 2024 | 15:43:33
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹79.94 Cr.(4.45%)
- Operating Profit₹4.73 Cr.(9.68%)
- Profit After Tax₹2.69 Cr.(0.20%)
- Operating Margin5.92%(NA%)
Note: Comparison is on YoY basis
Quarterly - Mangalam Drugs & Organics Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 79.94 | 87.47 | -% | 81.56 | -% |
| Selling/ General/ Admin Expenses Total | 10.18 | 8.89 | -% | 10.11 | -% |
| Depreciation/ Amortization | 3.97 | 3.42 | -% | 3.74 | -% |
| Other Operating Expenses Total | 20.40 | 16.19 | -% | 18.55 | -% |
| Total Operating Expense | 75.21 | 94.36 | -% | 83.12 | -% |
| Operating Income | 4.73 | -6.89 | -% | -1.56 | -% |
| Net Income Before Taxes | 1.20 | -10.29 | -% | -4.76 | -% |
| Net Income | 2.69 | -9.54 | -% | -3.56 | -% |
| Diluted Normalized EPS | 1.70 | -6.02 | -% | -2.26 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Nifty 50 jumps over 400 points, Sensex regains 80K. Experts recommend these 10 stocks to buy today
4 min read11:10 AM IST